Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hickey, M.
Right arrow Articles by Fraser, I.S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hickey, M.
Right arrow Articles by Fraser, I.S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 15, No. suppl_3, pp. 57-66, 2000
© 2000 European Society of Human Reproduction and Embryology

The structure of endometrial microvessels

M. Hickey1,3 and I.S. Fraser2

1 Imperial College School of Medicine at St Mary's, Department of Obstetrics and Gynaecology Norfolk Place, London W2 1PG 2 Sydney Centre for Reproductive Health Research, Family Planning NSW and Department of Obstetrics and Gynaecology, University of Sydney NSW 2006, Australia

Correspondence: 3 To whom correspondence should be addressed at: Imperial College School of Medicine at St Mary's, Department of Obstetrics and Gynaecology, Norfolk Place, London W2 1PG, UK. E-mail: m.hickey{at}ic.ac.uk

Recent studies have provided substantial evidence to highlight abnormalities in the structure of endometrial microvessels in users of progestogen-onlycontraception. Structural changes alone are unlikely to lead to breakthrough bleeding, but appear to be associated with a reduction in vessel integrity, and may reflect alterations in the control and growth of endometrial microvessels in those exposed to exogenous progestogens. In users of low-dose progestogens, immunohistochemical studies have demonstrated changes in superficial endometrial vascular morphology, density and in endometrial migratory cell populations. In Norplant users the endometrial endothelial basal lamina is deficient in the initial months of exposure, when bleeding problemsare most common. The basal lamina refers to the very thin structure consisting mostly of collagen IV and laminin seen underlying endothelial and epithelial cells at the electron microscope level. In addition, hysteroscopic studies have demonstrated increased fragility of superficial vessels. Changesin endometrial microvascular anatomy associated with normal menstruation have been reviewed, and are compared with those seen following contraceptive steroid exposure. Likely mechanisms of breakthrough bleeding such as increased superficial vascular fragility and the possible alterations in endometrial vascular structure leading to this are discussed.

Key words: breakthrough bleeding/endometrium/microvasculature/progestogens


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.